ESC 365 - Paradigm shifting evidence in TAVI – Evolut low risk trial and sub analyses.

Open Access

Paradigm shifting evidence in TAVI – Evolut low risk trial and sub analyses.

Session: Medtronic Leading with Evidence: Latest data from Evolut TAVI and Renal Denervation

Topic: Aortic Valve Stenosis

Speaker: Doctor J. Popma (Boston, US)

Sponsored by Medtronic

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Jeffrey Popma

Beth Israel Deaconess Medical Center, Boston (United States of America)

1 presentation

0 follower

5 more presentations in this session

Introduction and learning objectives.

Speaker: Doctor J. Popma (Boston, US)

The importance of valve hemodynamics – Why should it be a priority in TAVI?

Speaker: Professor M. Abdel-Wahab (Leipzig, DE)

A Pivotal moment for renal denervation.

Speaker: Professor M. Boehm (Homburg, DE)

Addressing the Population Question: Who is the Renal Denervation Patient?

Speaker: Professor A. Pathak (Monaco, MC)

Session conclusion and take home messages.

Speaker: Doctor J. Popma (Boston, US)

Access the full session

Medtronic Leading with Evidence: Latest data from Evolut TAVI and Renal Denervation

Speakers: Doctor J. Popma, Doctor J. Popma, Professor M. Abdel-Wahab, Professor M. Boehm, Professor A. Pathak...

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources